PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29055264-8	2018	Paroxetine treatment increased the levels of proinflammatory cytokines IFN-gamma, TNF-alpha, and IL-6 and decreased Th2 cytokine levels.	Paroxetine	0-10	interleukin 6	Homo sapiens	97-101	
29055264-9	2018	After paroxetine treatment, IL-6 levels increased more in the non-remitter group than in the remitter group.	Paroxetine	6-16	interleukin 6	Homo sapiens	28-32	
31375659-8	2019	Response to paroxetine treatment correlated with baseline IL-10, IL-6 and TNF-alpha levels, with the strongest signal being observed in males.	Paroxetine	12-22	interleukin 6	Homo sapiens	65-69	
19179025-8	2009	Serum IL-6 concentration in women treated with paroxetine decreased significantly.	Paroxetine	47-57	interleukin 6	Homo sapiens	6-10	
19179025-11	2009	CONCLUSION: Decrease in IL-6 concentration may be involved in the mechanism of the actions of both paroxetine and kamishoyosan in women with psychological symptoms, and IL-6 may therefore be useful as a marker of treatment.	Paroxetine	99-109	interleukin 6	Homo sapiens	24-28	
33545432-9	2021	These results suggest that plasma IL-6 level may be a promising biological marker for predicting the likely treatment response to paroxetine in individual patients with MDD.	Paroxetine	130-140	interleukin 6	Homo sapiens	34-38	
33602262-7	2021	RESULTS: All the SSRIs, including paroxetine, fluoxetine, sertraline, citalopram, and fluvoxamine, show a visible cytotoxicity within the range of applied doses, and a paradoxical effect on astrocytic inflammatory responses as manifested by the promotion of inducible nitric oxide synthase (iNOS) and/or nitric oxide (NO) and the inhibition of interleukin 6 (IL-6) and/or interleukin 1beta (IL-1beta).	Paroxetine	34-44	interleukin 6	Homo sapiens	344-357	
33602262-7	2021	RESULTS: All the SSRIs, including paroxetine, fluoxetine, sertraline, citalopram, and fluvoxamine, show a visible cytotoxicity within the range of applied doses, and a paradoxical effect on astrocytic inflammatory responses as manifested by the promotion of inducible nitric oxide synthase (iNOS) and/or nitric oxide (NO) and the inhibition of interleukin 6 (IL-6) and/or interleukin 1beta (IL-1beta).	Paroxetine	34-44	interleukin 6	Homo sapiens	359-363